Aytu Biopharma (AYTU) Amortization - Intangibles (2015 - 2026)

Aytu Biopharma (AYTU) has 12 years of Amortization - Intangibles data on file, last reported at $761000.0 in Q1 2026.

• On a quarterly basis, Amortization - Intangibles fell 17.28% year-over-year to $761000.0 in Q1 2026; TTM through Mar 2026 was $2.7 million, a 27.99% decrease from a year earlier, with the FY2025 full-year figure at $3.7 million, changed 0.0% from the prior year.
• Amortization - Intangibles for Q1 2026 stood at $761000.0, up from $526000.0 in the prior quarter.
• Over the last five years, Amortization - Intangibles for AYTU reached as high as $1.5 million in Q1 2022 and fell as low as $444000.0 in Q3 2025.
• Historically, Amortization - Intangibles has averaged $981588.2 across 5 years, with a median of $921000.0 in 2024.
• Across the five-year window, Amortization - Intangibles increased 3.43% in 2022 and slumped 51.79% in 2025, its largest moves.
• Year by year, Amortization - Intangibles stood at $1.2 million in 2022, then declined by 23.37% to $918000.0 in 2023, then rose by 0.33% to $921000.0 in 2024, then sank by 42.89% to $526000.0 in 2025, then surged by 44.68% to $761000.0 in 2026.
• Per Business Quant data, the three most recent Amortization - Intangibles figures were $761000.0 in Q1 2026, $526000.0 in Q4 2025, and $444000.0 in Q3 2025.